Risk factors for rifampin mono-resistant tuberculosis. (Q50883380)

From Wikidata

Revision as of 15:02, 27 April 2024 by ԱշբոտՏՆՂ (talk | contribs) (‎Added [hy] description: գիտական հոդված հրատարակված 1998 թվականի հունիսին, based on en:scientific article published in June 1998)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published in June 1998

Language	Label	Description	Also known as
English	Risk factors for rifampin mono-resistant tuberculosis.	scientific article published in June 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Risk factors for rifampin mono-resistant tuberculosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

0 references

1 reference

based on heuristic

inferred from title

11

object named as

Onorato IM

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Sarah E. Valway

8

object named as

Valway S

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

author name string

Ridzon R

1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Whitney CG

2

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

McKenna MT

3

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Taylor JP

4

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Ashkar SH

5

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Nitta AT

6

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Harvey SM

7

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Woodley C

9

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Cooksey R

10

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

157

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

6 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

1881-1884

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Nationwide survey of drug-resistant tuberculosis in the United States.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Molecular mechanisms of drug resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Rifampicin-resistant Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Drug malabsorption and resistant tuberculosis in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

21 January 2018

Identifiers

10.1164/AJRCCM.157.6.9712009

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9620922

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50883380&oldid=2138647347"